Home       About             Help      

Select plot or tool >
Pheno measurements correlated to your selected measurements

Pearson correlation p value
must be p ≤


Download all
At least
strains
in common
are required
Include:
females and males
females only
males only

Order by


More info on correlations


Your selected measurement:
behavior — exploratory         open field test  
Crowley1
pct_center_d120   center occupancy (percent of total time), day 120 (60d post-exposure)   [%]   haloperidol   60d
27 strains   age 9-28wks
  Inbred
 

Download this list as a tab-delimited file
 
Correlated measurement from anywhere in MPD
(organized by category)
Sex Pearson
r
p value
on r
Spearman
rs
# strains
in
common
Click
for
scatterplot
Log-
improved
Pearson
behavior – exploratory
Crowley1   pct_center_d60  
center occupancy (percent of total time), day 60 (haloperidol 60d)
male 0.91 p < 0.0001 0.90 26 Plot  
Crowley1   pct_center_d30  
center occupancy (percent of total time), day 30 (haloperidol 30d)
male 0.87 p < 0.0001 0.80 26 Plot  
Crowley1   pct_center_d0  
center occupancy (percent of total time), day 0
male 0.65 p = 0.0003 0.62 26 Plot 0.69
Brown1   trans_LD  
transitions between light and dark zones
male 0.80 p = 0.0019 0.80 12 Plot 0.84
behavior – involuntary movement
Crowley1   stereotypy_d60  
repeated breaking of the same beam (dur=60min), day 60 (haloperidol 60d)
male 0.75 p < 0.0001 0.82 26 Plot 0.82
Crowley1   stereotypy_d120  
repeated breaking of the same beam (dur=60min), day 120 (60d post-exposure) (haloperidol 60d)
male 0.68 p = 0.0001 0.75 26 Plot 0.78
Crowley1   stereotypy_d30  
repeated breaking of the same beam (dur=60min), day 30 (haloperidol 30d)
male 0.66 p = 0.0002 0.72 26 Plot 0.73
Crowley1   stereotypy_d0  
repeated breaking of the same beam (dur=60min), day 0
male 0.59 p = 0.0016 0.62 26 Plot 0.65
behavior – locomotor activity
Crowley1   vertical_actd30  
vertical activity (beam breaks) (dur=60min), day 30 (haloperidol 30d)
male 0.67 p = 0.0002 0.75 26 Plot 0.74
Crowley1   vertical_actd120  
vertical activity (beam breaks) (dur=60min), day 120 (60d post-exposure) (haloperidol 60d)
male 0.65 p = 0.0004 0.83 26 Plot 0.78
Crowley1   vertical_actd60  
vertical activity (beam breaks) (dur=60min), day 60 (haloperidol 60d)
male 0.64 p = 0.0004 0.82 26 Plot 0.73
Brown1   activity_LD  
total activity (line crosses plus rearing, dur=5min))
male 0.82 p = 0.0012 0.90 12 Plot 0.88
Crowley1   horizontal_actd120  
total distance traveled (dur=60min), day 120 (60d post-exposure) (haloperidol 60d)
male 0.59 p = 0.0015 0.73 26 Plot 0.78
Crowley1   horizontal_actd60  
total distance traveled (dur=60min), day 60 (haloperidol 60d)
male 0.55 p = 0.0038 0.73 26 Plot 0.75
Crowley1   vertical_actd0  
vertical activity (beam breaks) (dur=60min), day 0
male 0.51 p = 0.0077 0.51 26 Plot 0.58
behavior – social
Moy1   EntOBJ_soc  
number of entries into chamber with empty cage (a novel object), 10 min test
male 0.90 p = 0.0001 0.89 11 Plot  
Moy1   EntSTR2_nov  
number of entries into chamber with stranger2 (a second novel mouse), 10 min test
male 0.89 p = 0.0002 0.88 11 Plot  
Moy1   EntSTR1_soc  
number of entries into chamber with stranger1 (a novel mouse), 10 min test
male 0.88 p = 0.0004 0.92 11 Plot  
Moy1   EntSTR1_nov  
number of entries into chamber with stranger1 (former novel mouse), 10 min test
male 0.87 p = 0.0006 0.88 11 Plot  
behavior – visuospatial learning
Brown2   vis_acuit64  
visual acuity mean latency to reach cued platform, 0.64 threshold
male –0.89 p < 0.0001 –0.97 12 Plot -0.98
Brown2   vis_acuit32  
visual acuity mean latency to reach cued platform, 0.32 threshold
male –0.82 p = 0.0012 –0.85 12 Plot -0.89
Brown2   vis_acuit_ave_d8  
visual acuity mean latency to reach cued platform, incremental grating, day 8
male –0.80 p = 0.0016 –0.78 12 Plot -0.84
Brown2   acq_err_d1  
acquisition training mean errors, day 1
male 0.72 p = 0.0087 0.70 12 Plot  
blood – clinical chemistry – glucose
Naggert1   GLU_fat17  
glucose (plasma, 4h fast) (high-fat diet 17wks)
male 0.59 p = 0.0067 0.50 20 Plot  
blood – hematology – cell counts – WBC
Peters1   WBC  
white blood cell count (WBC; per volume x 103)
male –0.55 p = 0.0079 –0.57 22 Plot -0.58
blood – hematology – hemoglobin
Peters4   MCHC_M12  
mean RBC corpuscular hemoglobin concentration (MCHC) (age 12mo)
male –0.61 p = 0.0072 –0.75 18 Plot -0.69
blood – hematology – RBC parameters
CGDpheno1   MCV  
mean RBC corpuscular volume (MCV)
male 0.56 p = 0.0041 0.38 24 Plot  
blood – xenobiotics – drug and metabolite concentration
Rusyn2   DCV_cysteine2_tce  
S-(1,2-dichlorovinyl)-L-cysteine (serum DCVC, x 10-3), t=2h (trichloroethylene )
male 0.69 p = 0.0093 0.41 13 Plot  
brain – cerebral cortex
Wiltshire3   APOD_fluox  
apolipoprotein D (APOD), relative fluorescence intensity (fluoxetine )
male 0.78 p = 0.0004 0.78 16 Plot  
Wiltshire3   GSR_fluox  
glutathione reductase (GSR), relative fluorescence intensity (fluoxetine )
male 0.76 p = 0.0007 0.80 16 Plot  
brain – morphology
Wahlsten1   cc_area  
cross-sectional area of corpus callosum at midplane
male 0.69 p = 0.0063 0.70 14 Plot  
cardiovascular – ECG parameters
Maurer1   P_dur_at  
P-wave duration (atenolol 10mg/kg 2wks)
male –0.65 p = 0.0083 –0.60 15 Plot -0.70
ingestive preference – ethanol and saccharin
Finn1   saccharin  
consumption of 0.2% saccharin in water
male 0.69 p = 0.0084 0.69 13 Plot  
liver – protein homeostasis
Rusyn5   liver_BHMT_hfe  
betaine-homocysteine methyltransferase (BHMT), relative protein expression (high-fat diet and ethanol 4wks)
male 0.79 p = 0.0071 0.37 10 Plot  
 

34 rows

Reciprocals are included in the above list.

Correlations where Pearson r < 0.5 are not retained and will not appear in the above list.

All correlations available through MPD are mathematical correlations provided for exploratory use, and are not necessarily biologically significant. Additional forms of validation are required. Most correlations are based on strain mean data points which have varying degrees of quality, preciseness, and normality of distribution, and this is generally not taken into account in correlation strength metrics.




Hosted by:
  Contact us
About MPD
Also at JAX
  Units
Changelog
Downloads
  Citing
Funding
Terms of Use